Cabo Lab Medical: what changed
Cabo Lab Medical
Largest movements
- Cash +€38,771
up €38,771 (+1,534%), from €2,527 to €41,298
mainly Net result for the year (+€56,964) and Depreciation (+€9,776)
- Receivables within one year +€26,057
up €26,057 (+82.0%), from €31,760 to €57,817
- Tangible fixed assets -€8,676
down €8,676 (-31.8%), from €27,292 to €18,615
- Profit (loss) carried forward +€56,964
up €56,964 (+140%), from €40,572 to €97,536
- Other debts -€5,728
down €5,728 (-97.8%), from €5,859 to €131
- Tax, wage and social debts +€5,255
up €5,255 (+48.1%), from €10,930 to €16,185
- Gross operating margin +€29,117
up €29,117 (+53.5%), from €54,441 to €83,558
- Depreciation +€8,583
up €8,583 (+719%), from €1,193 to €9,776
- Taxes +€5,255
up €5,255 (+48.1%), from €10,930 to €16,185
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €62,708 | €119,089 | +€56,382 | +89.9% |
| Fixed assets | 21/28 | €27,292 | €18,615 | -€8,676 | -31.8% |
| Tangible fixed assets | 22/27 | €27,292 | €18,615 | -€8,676 | -31.8% |
| Furniture and vehicles | 24 | €27,292 | €18,615 | -€8,676 | -31.8% |
| Current assets | 29/58 | €35,416 | €100,474 | +€65,058 | +184% |
| Amounts receivable within one year | 40/41 | €31,760 | €57,817 | +€26,057 | +82.0% |
| Trade receivables | 40 | €31,760 | €57,817 | +€26,057 | +82.0% |
| Cash at bank and in hand | 54/58 | €2,527 | €41,298 | +€38,771 | +1,534% |
| Deferred charges and accrued income | 490/1 | €1,129 | €1,359 | +€231 | +20.4% |
| Total equity and liabilities | 10/49 | €62,708 | €119,089 | +€56,382 | +89.9% |
| Equity | 10/15 | €45,572 | €102,536 | +€56,964 | +125% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €40,572 | €97,536 | +€56,964 | +140% |
| Amounts payable | 17/49 | €17,135 | €16,553 | -€582 | -3.4% |
| Amounts payable within one year | 42/48 | €17,135 | €16,553 | -€582 | -3.4% |
| Trade debts | 44 | €347 | €237 | -€110 | -31.6% |
| Suppliers | 440/4 | €347 | €237 | -€110 | -31.6% |
| Taxes, remuneration and social security | 45 | €10,930 | €16,185 | +€5,255 | +48.1% |
| Taxes | 450/3 | €10,930 | €16,185 | +€5,255 | +48.1% |
| Other amounts payable | 47/48 | €5,859 | €131 | -€5,728 | -97.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,193 | €9,776 | +€8,583 | +719% |
| Other operating charges | 640/8 | €887 | €597 | -€290 | -32.7% |
| Gross operating margin | 9900 | €54,441 | €83,558 | +€29,117 | +53.5% |
| Operating profit (loss) | 9901 | €52,361 | €73,185 | +€20,824 | +39.8% |
| Financial charges | 65/66B | - | €36 | +€36 | |
| Recurring financial charges | 65 | - | €36 | +€36 | |
| Profit (loss) for the period before taxes | 9903 | €52,361 | €73,149 | +€20,788 | +39.7% |
| Income taxes | 67/77 | €10,930 | €16,185 | +€5,255 | +48.1% |
| Profit (loss) for the period | 9904 | €41,431 | €56,964 | +€15,533 | +37.5% |
| Profit (loss) for the period to be appropriated | 9905 | €41,431 | €56,964 | +€15,533 | +37.5% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.